319 related articles for article (PubMed ID: 24529303)
1. The diagnosis and treatment of idiopathic pulmonary fibrosis.
Behr J
Dtsch Arztebl Int; 2013 Dec; 110(51-52):875-81. PubMed ID: 24529303
[TBL] [Abstract][Full Text] [Related]
2. [Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].
Behr J
Dtsch Med Wochenschr; 2012 Mar; 137(12):601-4. PubMed ID: 22415624
[TBL] [Abstract][Full Text] [Related]
3. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
4. Interstitial Lung Disease: A Review.
Maher TM
JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
[TBL] [Abstract][Full Text] [Related]
5. Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes.
Cottin V
Eur Respir Rev; 2012 Jun; 21(124):161-7. PubMed ID: 22654089
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic Pulmonary Fibrosis].
Prasse A
Pneumologie; 2015 Oct; 69(10):608-14; quiz 615. PubMed ID: 26444136
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone.
Varone F; Mastrobattista A; Franchi P; Viglietta L; Poletti V; Tomassetti S; Dubini A; Tagliaboschi L; Calandriello L; Farchione A; Larici AR
Clin Respir J; 2018 Jan; 12(1):347-351. PubMed ID: 27322356
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Xaubet A; Serrano-Mollar A; Ancochea J
Expert Opin Pharmacother; 2014 Feb; 15(2):275-81. PubMed ID: 24308635
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K
BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941
[TBL] [Abstract][Full Text] [Related]
10. Marked Improvement with Pirfenidone in a Patient with Idiopathic Pulmonary Fibrosis.
Miyamoto A; Morokawa N; Takahashi Y; Ogawa K; Takeyasu M; Murase K; Hanada S; Uruga H; Mochizuki S; Takaya H; Kurosaki A; Kishi K
Intern Med; 2016; 55(6):657-61. PubMed ID: 26984086
[TBL] [Abstract][Full Text] [Related]
11. [Idiopatic pulmonary fibrosis - news in multidisciplinary diagnostic and therapeutic approaches].
Vašáková M; Matěj R
Cesk Patol; 2016; 52(2):85-92. PubMed ID: 27223586
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena.
Vietri L; Cameli P; Perruzza M; Cekorja B; Bergantini L; d'Alessandro M; Refini RM; Pieroni M; Fossi A; Bennett D; Spalletti M; Mazzei MA; Sestini P; Rottoli P; Bargagli E
Ther Adv Respir Dis; 2020; 14():1753466620906326. PubMed ID: 32066332
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.
Nathan SD; Costabel U; Albera C; Behr J; Wuyts WA; Kirchgaessler KU; Stauffer JL; Morgenthien E; Chou W; Limb SL; Noble PW
Respir Med; 2019 Jul; 153():44-51. PubMed ID: 31153107
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic criteria and possible treatment of idiopathic pulmonary fibrosis].
Bendstrup E; Hyldgaard C; Hilberg O
Ugeskr Laeger; 2014 Apr; 176(18):. PubMed ID: 25351567
[TBL] [Abstract][Full Text] [Related]
15. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report.
Ikeda S; Sekine A; Baba T; Yamakawa H; Morita M; Kitamura H; Ogura T
BMC Pulm Med; 2016 Mar; 16():38. PubMed ID: 26940352
[TBL] [Abstract][Full Text] [Related]
16. A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR study.
Majewski S; Białas AJ; Buchczyk M; Gomółka P; Górska K; Jagielska-Len H; Jarzemska A; Jassem E; Jastrzębski D; Kania A; Koprowski M; Krenke R; Kuś J; Lewandowska K; Martusewicz-Boros MM; Roszkowski-Śliż K; Siemińska A; Sładek K; Sobiecka M; Szewczyk K; Tomczak M; Tomkowski W; Wiatr E; Ziora D; Żołnowska B; Piotrowski WJ
BMC Pulm Med; 2020 May; 20(1):122. PubMed ID: 32366291
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of Idiopathic Pulmonary Fibrosis.
Kishaba T
Respir Investig; 2019 Jul; 57(4):300-311. PubMed ID: 30853366
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment.
Martinez FJ; Flaherty KR
Chest; 2017 May; 151(5):1173-1174. PubMed ID: 28483105
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.
Glass DS; Grossfeld D; Renna HA; Agarwala P; Spiegler P; Kasselman LJ; Glass AD; DeLeon J; Reiss AB
Respir Investig; 2020 Sep; 58(5):320-335. PubMed ID: 32487481
[TBL] [Abstract][Full Text] [Related]
20. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
